Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer

Authors :: Takaaki Kobayashi
K. Kawai
Fumio Nagashima
J. Furuse
Daisuke Naruge
Naohiro Okano
Source :: Annals of Oncology. 27:vi237
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Biliary tract cancer
Refractory
business.industry
Internal medicine
Medicine
Hematology
business
Second line chemotherapy
Gemcitabine
medicine.drug

Full Text Access

Tools